Exagen Inc. Reports on Shareholder Vote Matters

Ticker: XGN · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1274737

Exagen Inc. 8-K Filing Summary
FieldDetail
CompanyExagen Inc. (XGN)
Form Type8-K
Filed DateJun 11, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, filing-update

TL;DR

EXAGEN shareholders voted on something important June 10th.

AI Summary

Exagen Inc. filed an 8-K on June 11, 2025, reporting on matters submitted to a vote of security holders on June 10, 2025. The filing details the company's corporate structure, including its incorporation in Delaware and its principal executive offices located at 1261 Liberty Way, Vista, CA 92081. The report also notes Exagen Inc.'s former name, Exagen Diagnostics Inc., with a name change effective December 30, 2003.

Why It Matters

This filing indicates that Exagen Inc. held a shareholder vote, which is a key governance event that can impact corporate decisions and shareholder rights.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote and does not contain information about significant financial changes or operational risks.

Key Players & Entities

  • EXAGEN INC. (company) — Registrant
  • June 10, 2025 (date) — Date of earliest event reported
  • June 11, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of incorporation
  • 1261 Liberty Way, Vista, CA 92081 (address) — Principal executive offices
  • Exagen Diagnostics Inc. (company) — Former company name
  • December 30, 2003 (date) — Date of name change

FAQ

What specific matters were submitted for a vote by Exagen Inc. security holders on June 10, 2025?

The filing states that matters were submitted to a vote of security holders on June 10, 2025, but does not specify the exact nature of these matters within the provided text.

When was Exagen Inc. incorporated, and in which jurisdiction?

Exagen Inc. was incorporated in Delaware, as indicated by the filing.

What is the address of Exagen Inc.'s principal executive offices?

The principal executive offices of Exagen Inc. are located at 1261 Liberty Way, Vista, CA 92081.

What was Exagen Inc.'s former name, and when did the name change occur?

Exagen Inc.'s former name was Exagen Diagnostics Inc., and the name change was effective on December 30, 2003.

What is the SEC file number for Exagen Inc.'s 8-K filing?

The SEC file number for Exagen Inc. is 001-39049.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding EXAGEN INC. (XGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.